Company research

Belite Bio, Inc. ADR (BLTE)

Business and financials

Estimated market cap

Unavailable

A supported share count and cached closing price are required.

Annual report for the year ended 2025-12-31. These are reported annual figures, not trailing twelve-month estimates.

A business excerpt is not available. Read the annual report for the company’s description.

Revenue: Unavailable; No comparable standard-tagged figure in this annual period.
Net income: -77.61M USD; 2025-01-01 to 2025-12-31
Filed 2026-03-31 ↗
Diluted EPS: -2.31 USD / share; 2025-01-01 to 2025-12-31
Filed 2026-03-31 ↗
Operating cash flow: -36.99M USD; 2025-01-01 to 2025-12-31
Filed 2026-03-31 ↗
Cash and equivalents: 352.93M USD; As of 2025-12-31
Filed 2026-03-31 ↗
Total assets: 780.56M USD; As of 2025-12-31
Filed 2026-03-31 ↗

Source: SEC Company Facts. Checked 2026-10-05. Data is refreshed in the background. Missing or ambiguous figures are left unavailable.

Loading SEC business and financials…

AI relationship research has not yet been verified for this company.

Listing data synced 2026-09-10.

Loading your outlook…

Loading…

Loading company activity...